ArvindBagga India

Upload Picture

First Name

Arvind

Last Name

Bagga

Institution

Country.

India

Friday, February 7, 2025

Time	Session

9:45 a.m. 11:15 a.m.	CKD-MBD Insights and Innovations for 2025 and Beyond: No Bone Left Uncovered ArvindBagga Chair India UttaraDas Chair All IndiaInstitute of Medical Science MangalagiriIndia What Should a Clinician Know About CKD-MBD in 2025? HanneJoergensen Speaker Aarhus UniversityDenmark CKD-MBD in Children and Young Adults: What's the Difference? SukanyaGovindan Speaker Mehta Children's Hospitals and MGM healthcare, Chennai, IndiaIndia Progress in CKD-driven Vascular Calcification: From Bench to Bedside MarcVervloet Speaker Radboud University Medical center, The NetherlandsNetherlands How to Use Serum Biomarkers for Optimal Management of CKD-MBD SandroMazzaferro Speaker Sapienza University of Rome, ItalyItaly Q&A Gulmohar Hall 302	State of the Art Insights Into Pregnancy and Pediatric Thrombotic Microangiopathies ArvindBagga Chair India DavidKavanagh Chair National Renal Complement Therapeutics Centre United Kingdom VinayRathore Chair All India Institute of Medical Sciences- RaipurIndia Outcomes From the ISN Haemolytic Uraemic Syndromes Forum: A Comprehensive Review DavidKavanagh Speaker National Renal Complement Therapeutics Centre United Kingdom Differential Diagnosis and Treatment of TMAs in Pregnancy ShilpanjaliJesudason Speaker Royal Adelaide Hospital and University of Adelaide, AustraliaAustralia Factor H Autoantibodies in aHUS AditiSinha Speaker Department of Pediatrics, All India Institute of Medical SciencesIndia aHUS in Paediatric Populations Lap Tak Alison MA Speaker Hong Kong Children\'s Hospital Hong Kong, China Q&A Parijat Hall 201